Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stock is at 0.75$.
Stock is at 0.08$ & bid is at 0.064$. That’s the next stop. No buyers. Only sellers & sells. This stock is doomed. Don’t listen to paid pumpers. They don’t put their money where their mouth is.
We all knew the risks: SMI probably won't pay $4 million in 2024 and the clinical trials could take longer than expected.
So here we are. The PPS will probably stagnate and bleed in 2024 as we wait for clinical trials to finish. This stock is going to stay under the radar. Weak hands will bail and our one basher will wail and gnash his teeth and drown us in hyperbole.
The Form 4's show that insiders are buying and holding. I'm following them, not the complainer.
Every time you post, I'm going to remind you and everyone else of the time you used two aliases to hold a fake conversation to bash this stock, in a violation of iHub rules.
I mean, what kind of lowlife does that? And why should anyone care what that kind of lowlife thinks about any given stock?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170028328
Flood, Fire, and Famine. Doom, Defeat, and Despair.
Are you going to play this FUD dirge every day?
A fresh sell of 10 K stock at 0.085$. Stock is at multiyear low. The next stop will be 0.05$ or even 0.01$ or even below. This stock is doomed.
a short position now of 26,500 now??? Thats a menacing notional value of $2600.00. WOW!!! I see a real short squeeze coming
Bid is at 0.08$ & ask is at 0.09$ & still there are no buyers. When sellers want to sell at 0.09$ & yet neither there are any buys nor any buyers. There are only sellers & sells only. All of you will get the picture. This stock situation is getting from-bad-to-worse-to-worst. Those who are bullish, they are not buying at any price. All of you can get the picture.
A short increase from 7.5k to 26K?
And that's shorting pressure, in your mind?
Good lord, you're pathetic.
As of 4/15 26K stock is shorted. As of 3/28 the total shorts were just 7.5K stock. So between 3/28 & 4/15, almost 3 times more stock was shorted. Someone knows something very bad is happening with this. There are 32K stock available at a bargain basement price of just 10 cents & still no buyers. This stock is in a very bad situation.
Someone just now sold 35K stock at a bargain basement price of 0.09$. It’s bad news after bad news after bad news. it’s totally worst here. Neither any buyers nor any buying support. It’s just sell sell & more sell at any price one can get. Just get out of long position for any salvage price one can get. Very bad situation.
"Heavy selling?" This stock has an avg of 23,000 shares traded per day and there is "heavy selling?" I don't see "heavy" anything here.
And where do you see 10M shares available at .10 -- I see about 10,000 available at .10 and I've NEVER seen 10M available at any price.
And why do you say this stock "has become a laughing stock & puppet in the hands of market-makers / broker-dealers?" I don't get that impression at all. I see a thinly traded stock, period.
Nobody is paying attention to you, sorry. I think you should bring back your second alias and have another fake conversation with yourself. Remember when you did that? It's been awhile. We miss the fun. You were accusing the CEO and Directors of stealing $3.3 million and spending it in a Vegas strip club.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170028328
This stock is in huge trouble. As soon as it even tries to go up, heavy selling brings it back down. This stock has become a laughing stock & puppet in the hands of market-makers / broker-dealers. As soon as 10K stock was bought, immediately 15K stock was sold. Right now there are almost 10M stock available at bargain basement price of 0.10$ (just 10 cents) & still there are no buyers. Very sad disappointing & pathetic state of affairs for the stock
You think there are "huge sells?"
Avg volume is 25,000 per day. That's about $2500 per day. But there are "huge sells?" News flash: there isn't huge ANYTHING here. This stock is WAY under the radar.
You keep issuing ridiculous challenges -- so here's a challenge for you. You are so bearish on this stock -- SHORT IT. I STRONGLY urge you to short the heck out of this stock. Borrow money. Take out a second mortgage. Please. Short it hard.
If you don't short it, you're full of shit. End of story.
I'm holding with the insiders who own half of the O/S. There's only 56 million shares outstanding so let the weak hands sell their $2500 worth of stock every day until they're out. Fine with me. Take it lower and I'll keep accumulating through 2024.
When the US clinical trials are done, and when the results are good, and when they submit the FDA application, and when the Luviva Scan gets approved by the FDA... there's four catalysts that will each cause a PPS spike. It's delayed until 2025 now but it's all going to happen. Yes, we have to listen to you whine and complain and stamp your feet and shake your fists for that entire time, and we'll have to listen to the pseudo-lawyer complain about how he's been lied to and cheated and abused by those mean businessmen, but having to listen to whiners and complainers is part of the price of gambling on OTC stocks.
And gambling is what we're doing here. If you don't have the stomach (or the finances) for gambling you are in the wrong place.
This is very bad. This stock is in huge trouble. There are sells happening even at 0.09$. The saga continues. Huge sells at any bargain basement price as if long stockholders want to get out of their long positions at any salvage price they can get. Management is silent & broker-dealers / market-makers are taking a full advantage. Chances of this stock going above 0.15$ & staying above 0.15$ are slim to none,
You present GIUL as a savvy legal expert who was wronged by Shenghou.
But how savvy is GIUL, considering that:
* GIUL signed that contract without reading it.
* GIUL initially sued Faupel and Blumberg for 10 counts, but the court threw out six of those before the case went to court.
* When the case went to court, the judge then threw out GIUL's conspiracy claims, leaving only three counts remaining.
https://masslawyersweekly.com/files/2024/03/09-024-24.pdf
I understand that this is common in law -- throw a bunch of spaghetti against a wall and see what sticks -- but getting seven out of 10 counts thrown out doesn't give me much confidence in GIUL.
And the trial changed from a jury trial to a Directed trial -- at whose request was that done, GIUL or Shenghou?
Regardless -- Guided Therapeutics is not a party to the case and so there are no claims in the case against Guided Therapeutics. I have no doubt that if GIUL loses the remaining three counts, GIUL will throw more spaghetti against the wall and bring more lawsuits, but this forum is a poor place to whine and complain about how poorly GIUL was treated and abused. A savvy legal expert would find a better way to air grievances.
bullshit. GIUL won't have grounds to sue Guided Therapeutics if defendants don't pay.
Guided Therapeutics can't be held liable for the actions of Shenghou, not back then, not now.
And to think - if GIUL had just read the contract before signing it.... who signs a contract without reading it? I'm not a lawyer but I know enough to read a contract before signing it.
And now GIUL is accusing BOTH Blumberg and Faupel of perjury? What is the purpose of making those accusations here? Seems malicious and libelous. I wonder what the judge will say about THIS.
Faupel and Blumberg are being sue for deceiving plaintiff GIUL LLC: not telling the truth in the first place in a fund raising Securities transaction, telling half truths, making misrepresentations, not making material disclosures in raising funds, and engaging in unfair and deceptive practices. Blumberg an Attorney is accused of telling lies on the stand under oath amounting to Perjury - as Blumberg engaged in after-the-fact personal invention of the facts.
GIUL, LLC is suing because it was deceived by Faupel and Blumberg and it did not, because of their deception, know material facts when it made its loan to Shenghou, LLC, an entity Faupel and Blumberg managed/controlled and they both own investment interests in.
Giul, LLC is also of the opinion that Faupel lied in both his deposition and on the stand at trial, thus committed Perjury to avoid having a Judgment issued against him.
Should Giul, LLC prevail in its case, GIUL will have grounds to Sue Guided Therapeutics If defendants don't satisfy - pay Giul's Judgment against defendants. Giul LLC intends and is prepared to do exactly that.
All the things you complain about were things that you knew when you invested. Seems malicious and unethical to complain about them now, many years later, considering that the current lawsuit names Blumberg and Faupel as defendants but does not name Guided Therapeutics as a defendant.
But that's just my opinion. The judge might see it differently. Best of luck.
I am a shareholder in GTHP who has lost a fair amount of money. So I will say what I think is the truth about GTHP and its Officers and Directors.
Tell it to the judge.
Pointing out the truth of your Red Flag Disclosure on the 8k you posted.
Pointing out the Half Truths, Implied misrepresentation that GTHP getting all of SMI revenues and non-disclosure that Shenghou, LLC sharing in this revenue in the Item 13 you published.
Does the judge know you're bashing GTHP on a stock message board while you wait for his decision?
Aren't you worried that this will influence the judge's decision? Seems unethical and malicious.
If I were Faupel or Blumberg I'd bring this bashing to the court's attention.
Myjog: What do you think of this RED FLAG
Again Shenghou, LLC the original License holder with GTHP did not have the expertise to fulfill its obligations per said agreement from the onset and thus in my personal opinion it was a Sham transaction and Shenghou had to find a replacement - Thus SMI. Shenghou getting to keeps - share fees that GTHP gets from SMI.
RED FLAG GTHP DIRECTORS EFFECTIVELY WAIVED CONFLICT OF INTEREST PROVISIONS OF GTHP'S CODE OF ETHICS
THIS SOUNDS LIKE TURNING A BLIND EYE TO UNETHICAL - CONFLICT OF INTEREST BEHAVIOR BY FAUPEL AND BLUMBERG
What is MOST INTERESTING about GETS posting of 8k item is that in referencing the fee splitting agreement is: GTHP (disinterested Directors "effectively waived the conflict-of-interest provisions of the Company’s code of ethics." "On January 15, 2017, each of the disinterested directors on the Company’s Board of Directors, having considered the interests of Dr. Faupel and Mr. Blumberg and having approved the agreement, effectively waived the conflict-of-interest provisions of the Company’s code of ethics." THIS LOOKS LIKE A RED FLAG TO ME
I will again say that Shenghou LLC the original License Agreement Holder was a sham transaction, as Shenghou did not have the expertise to fulfill its obligation under the same, and perhaps it is a self directed dealing of GTHP assets - Splitting GTHP fees to insiders Faupel and Blumberg who are owners in Shenghou., LLC. and perhaps GTHP effectively waived its conflict of interests code to allow Faupel and Blumberg to receive compensation at the expense of the shareholders of GTHP, without having to disclose this as compensation to these two insiders at GTHP. I would call this turning a blind eye.
I was clearly saying non-disclosure in response to your posting of Item 13 from a 10k. And I explained further even after my retraction why I still view this as an inadequate - thus non disclosure in case you missed that.
GET: Item 13 which you posted:
Is 100% absent any disclosure that GTHP has to share fees it receives from SMI,(with Shenghou, LLC) which implies GTHP is retaining all these fees, this is a half truth and misrepresentation and thus in my viewpoint a non disclosure. I will leave it at that and I have never had a problem with you individually.
GTHP can find a different subcontractor in China -- that's what SMI is.
If GTHP’s management would have been serious about finding another subcontractor in China then they would have already found one by now. What’s GTHP management’s vested interests in keeping a Chinese partner that can’t be trusted and have proved to be contract-breaching and not-paying?
———
A Chinese subcontractor that actually has some money.
Agree with you on that. GTHP must find another partner in China that can pay GTHP as per contract.
———-
I wouldn't expect a PR for that extra $100,000 since there wasn't a PR for the $330,000 -- if SMI submits the application to the NMPA in second quarter as promised, there will be a PR then, I believe. And if they don't and the application to the NMPA never gets submitted, worst case scenario, that Chinese clinical trial with 400 patients will help Guided get FDA approval.
There must be a PR from GTHP about whether or not SMI paid them 100K as per “standstill contract” by March 24 end? SMI is supposed to submit for NMPA in 2nd Q & at that time they are supposed to trigger a PO and pay additional amount to GTHP. For stockholders this is a very critical & crucial step. Stock hasn’t been trading at all & it’s because of this debacle with SMI, stock lost more than 40% value. Why GTHP management continue to partner with a subcontractor in China who is neither paying GTHP nor honouring contract/s? They say stop the habit of collecting red flags. In spite of having so many red flags about SMI, why GTHP’s management continues to partner with them?
GTHP can find a different subcontractor in China -- that's what SMI is.
A Chinese subcontractor that actually has some money.
SMI paid $330,000 according to the 10-K and that's more than I thought they would pay. I wouldn't expect a PR for that extra $100,000 since there wasn't a PR for the $330,000 -- if SMI submits the application to the NMPA in second quarter as promised, there will be a PR then, I believe. And if they don't and the application to the NMPA never gets submitted, worst case scenario, that Chinese clinical trial with 400 patients will help Guided get FDA approval.
So I'm just not feeling the FUD that you and the other FUDster are selling. The Brothers Fudd. Which one is Elmer?
Have a FUD-filled weekend. Perhaps a nice vinegar pie would hit the spot.
GTHP has yet to publish whether or not SMI paid them 100K by March 31st 2024?
GTHP can’t alone submit to NMPA without SMI. If & when SMI will submit to NMPA (& that’s a big if) they are supposed to trigger a PO. Without that PO’s money coming in stock has no where else to go but downward spiral.
Because they finished the Chinese clinical trial and have the endorsement of Chinese gynecologists.
submission to the Chinese FDA can now happen whether SMI does it or not.
On why basis you say this? ☝️
Retracting your assertion of non-disclosure is like saying you're sorry after damaging someone's property. That doesn't repair the damage. The company can sue you for libel.
You're a lawyer. You know that.
GET: Item 13 which you posted:
Is 100% absent any disclosure that GTHP has to share fees it receives from SMI,(with Shenghou, LLC) which implies GTHP is retaining all these fees, this is a half truth and misrepresentation and thus in my viewpoint a non disclosure. I will leave it at that and I have never had a problem with you individually.
GET
Thanks for bringing this to my attention that this was mentioned in a 8k, which I never saw or knew about until you posted it, this can be said for other investors as well whom did not know about the GTHP - Shenghou fee split agreement. So I hereby immediately RETRACT MY COMMENT OF NON DISCLOSURE.
THE ITEM 13 YOU QUOTED:
13. SUBSEQUENT EVENTS
On February 17, 2024, the Company entered into a fourth amendment to the agreement with SMI. Under the terms of the amended agreement, SMI also agreed to pay the Company $531,100 on or prior to March 15, 2024. MAKES IT SOUND LIKE GTHP GETS ALL THESE FESS AND DOES NOT REFERENCE THAT THESE FEES ARE TO BE SHARED WITH SHENGHOU LLC , so perhaps this is misleading by not referencing again a fee spliting arrangement that most investors like yourself were unaware of.
What is MOST INTERESTING about your posting referencing the fee splitting agreement is: GTHP (disinterested Directors "effectively waived the conflict-of-interest provisions of the Company’s code of ethics." "On January 15, 2017, each of the disinterested directors on the Company’s Board of Directors, having considered the interests of Dr. Faupel and Mr. Blumberg and having approved the agreement, effectively waived the conflict-of-interest provisions of the Company’s code of ethics." THIS LOOKS LIKE A RED FLAG TO ME
I will again say that Shenghou LLC the original License Agreement Holder was a sham transaction, as Shenghou did not have the expertise to fulfill its obligation under the same, and perhaps it is a self directed dealing of GTHP assets - Splitting GTHP fees to insiders Faupel and Blumberg who are owners in Shenghou., LLC. and perhaps GTHP effectively waived its conflict of interests code to allow Faupel and Blumberg to receive compensation at the expense of the shareholders of GTHP, without having to disclose this as compensation to these two insiders at GTHP. I would call this turning a blind eye.
I saw that the judge threw out GIUL's conspiracy claims. Tell us what you know about that.
https://masslawyersweekly.com/files/2024/03/09-024-24.pdf
I just posted the link to the agreement -- and it was FREE.
That agreement has been in black-and-white for GTHP investors to see for quite some time. It is already DISCLOSED so you can stop posting your libelous statements, please and thank you.
I fail to see this agreement as a negative for GTHP investors. Shenghuo only gets money if SMI pays money. More important, without that agreement there would have been no SMI and there would be no Chinese clinical trials completed, because obviously Shenghuo wasn't going to accomplish anything in China.
The REAL value here is in the FDA approval. That's going to take awhile but I'm quite confident that this time the FDA will approve the device. FDA approval has nothing to do with your lawsuit and it has nothing to do with Shenghuo. If SMI pays any money, that will be icing on the cake (they already paid $330,000), but even if they don't pay any more money, they already accomplished a valuable feat: Chinese clinical trials were completed without costing Guided a lot of money, and the submission to the Chinese FDA can now happen whether SMI does it or not.
That has nothing to do with Guided Therapeutics and is therefore off topic.
Have your attorney send Mark Faupel a certified letter requesting that he disclose to you the terms of the agreement whereby GTHP has to share SMI revenue with the prior License Holder Shenghou, LLC. It should cost you less than 500 bucks. I will reimburse you for the same.
GIUL LLC law suit vs Mark Faupel, CEO of GTHP and Richard P. Blumberg, Director of GTHP, has been completed.
The Judge in the case is also acting as Jury and will fully decide the matter now pending and awaiting his ruling decision.
GIUL LLC in its submission of finding of facts claims Richard P. Blumberg told numerous lies when he testified under oath on the stand. Should the superior court trial judge agree on this issue that Blumberg committed perjury when he testified under oath - GIUL LLC will file a complaint with the SEC against Blumberg.
I don't believe you because one of these must be true:
* You are lying and therefore guilty of libel;
OR
* You are disclosing insider information and that is illegal.
Either way -- why should anyone trust you?
I believe the first bullet above describes the situation. The agreement to which you refer is disclosed in the financial statement as Exhibit 10.13, which makes YOU guilty of libel. Here is Exhibit 10.13 from the 10-K:
https://content.edgar-online.com/ExternalLink/EDGAR/0001121781-17-000006.html?hash=4440d5c8e862c59bf3763cf92d5c1b90ff360893e0a6c1f7044372876f5bc32a&dest=ex10two_htm#ex10two_htm
GTHP has a NON DISCLOSED AGREEMENT where GTHP has to share revenue from SMI with the previous License Holder Shenghou LLC, now know as K2, of which Richard Blumberg, now a board of Director Member of GTHP,, - Blumberg is also a manager of K2 and owns a portions of K2.
Again, I view this as self dealing assets of GTHP by insiders to themselves Blumberg and Mark Faupel also an owner of K2 (Faupel at one point was also a manager of K2). P
erhaps Faupel and Blumberg will be sued here by Shareholder of GTHP for self dealing assets - cash flow owed GTHP by SMI to an entity both Blumberg and Faupel are owners of at the expense to GTHP Shareholders?
Each of the 3 factual points you claim to have knowledge and understanding on is flat out WRONG!!! You really should check your facts before making such ridiculous comments as you are really just embarrassing yourself. Further, you must think you are the smartest guy in the room with your "Put your money where your mouth" challenge...give your head a shake man!!!!!
Do YOU have anything but FUD?
The clinical trials are taking longer than predicted. Do you ever read the filings, or do you just wait for me to explain them to you?
The clinical trials didn't finish in March 2024 as projected. That's the reason for the PPS decline. Accept that, or move on.
Do you have anything other than same old broken record FUD?
This company has a technological great product. However that product is in the wrong hands.
If you think this stock is undervalued or this stock has a potential to go up, then start buying. It’s time to put your money where your mouth is.
Do you know what FUD means?
Fear Uncertainty Doubt.
"This stock is at multi-year low" is a lie.
"In last 7+ years GTHP never saw a green day" is a lie.
"this stock will never see a day when it will close above 0.15$ & stay above 0.15$" is bullshit.
You are the FUD poster child. Congratulations.
Stock is at multi-year low & all of a sudden all bulls vanish. 😂
It’s time to finally admit that a great technological product like LuViva is in the wrong hands. Because of that long stockholders are suffering losses-over-losses-over-losses.
In last 7+ years GTHP never saw a green day.
As I said multiple times before this stock will never see a day when it will close above 0.15$ & stay above 0.15$
Open challenge to anyone to get this stock over 0.15$
Did you get a chance to read latest 10K?
Is there any good news in the latest 10K? Or is it still doom-&-gloom? SMI paying GTHP something that’s better than SMI paying GTHP nothing. Right? Is it time to slap a buy on ask? Or not yet?
I didn't read the 10-K word-for-word but I searched for some important strings. Here's the most interesting part:
13. SUBSEQUENT EVENTS
On February 17, 2024, the Company entered into a fourth amendment to the agreement with SMI. Under the terms of the amended agreement, SMI also agreed to pay the Company $531,100 on or prior to March 15, 2024. On March 18, 2024, SMI, through SMI’s authorized distribution partner, initiated a wire payment of $330,000 in partial satisfaction of $531,100 owed to the Company. The payment was received by the Company on March 20, 2024. As the full payment was not received by March 15, 2024, the Company had the right to terminate the agreement with two weeks’ notice to SMI, however the Company did not exercise this option.
The amended agreement also provides for a timeline for the Company to deliver inventory during 2024, including LuViva devices and components, as well as approximately 1,640,000 RFID chips. In consideration, SMI agreed to pay a total of $4.4 million during 2024, including the payments due on March 15, 2024.
On March 27, 2024, the parties entered into a Standstill Agreement (the “Standstill Agreement”). The parties agreed that SMI will make a nonrefundable payment of $100,000 to the Company prior to March 31, 2024. In exchange, the Company will not initiate any legal proceedings, including but not limited to filing a lawsuit, obtaining a judgement, or enforcing any security interest, as related to the March shortfall in payments of $201,100, until April 30, 2024. Upon paying $100,000, SMI will have the option to extend the Standstill Agreement until June 15, 2024 by making a nonrefundable payment to the Company of $150,000. One additional payment of $150,000 may be made to extend the standstill rights until July 30, 2024, if mutually agreed upon. If SMI is unable to make the payments pursuant to the Standstill Agreement, the Company agreed to seek loans on behalf of SMI to cover the payments. SMI agreed to reimburse the Company for these loans along with all expenses associated with them within three months of the loans being issued as long as the loans are used solely for (1) parts for LuViva devices to be used by SMI for marketing and promotional activities, or (2) labor or consulting fees connected to providing parts, assemblies of devices or disposables to SMI. Additionally, SMI confirmed its commitment to make payments to GTI of at least $4.0 million during 2024 and as part of this commitment will make payments of $200,000 and $500,000 by the end of May 2024 and July 2024, respectively, to ensure that the program commercialization proceeds according to schedule.
Blumberg just exercised warrants for 30 cents. See the newest Form 4.
Here's the reason why the judge in that civil case against Blumberg and Faupel ruled against a jury trial and directed the case to the court instead:
https://masslawyersweekly.com/files/2024/03/09-024-24.pdf
Trial ended, and they're waiting for the judge's decision. I've been following it here:
https://trellis.law/cases/1984CV02862?state=ma
Followers
|
107
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
15650
|
Created
|
11/06/16
|
Type
|
Free
|
Moderators GetSeriousOK |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |